{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T00:28:03Z","timestamp":1768004883306,"version":"3.49.0"},"reference-count":89,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"vor","delay-in-days":366,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.cmi.2015.03.026","type":"journal-article","created":{"date-parts":[[2015,4,16]],"date-time":"2015-04-16T05:45:38Z","timestamp":1429163138000},"page":"797.e9-797.e17","source":"Crossref","is-referenced-by-count":25,"title":["Current knowledge and future perspectives on acute hepatitis C infection"],"prefix":"10.1016","volume":"21","author":[{"given":"S.J.","family":"Hullegie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.E.","family":"Arends","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.J.A.","family":"Rijnders","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.L.","family":"Irving","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Salmon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Prins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.M.","family":"Wensing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Klenerman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Leblebicioglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Boesecke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.K.","family":"Rockstroh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.I.M.","family":"Hoepelman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl.\u00a01","key":"10.1016\/j.cmi.2015.03.026_bib1","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1478-3231.2008.01934.x","article-title":"The global burden of hepatitis C","volume":"29","author":"Lavanchy","year":"2009","journal-title":"Liver Int"},{"issue":"1","key":"10.1016\/j.cmi.2015.03.026_bib2","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1365-2893.2005.00651.x","article-title":"Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies","volume":"13","author":"Micallef","year":"2006","journal-title":"J\u00a0Viral Hepat"},{"key":"10.1016\/j.cmi.2015.03.026_bib3","series-title":"Annual report on the state of the drugs problem in Europe: European Monitoring Centre for Drugs and Drug Addiction","year":"2010"},{"issue":"7","key":"10.1016\/j.cmi.2015.03.026_bib4","doi-asserted-by":"crossref","first-page":"e103345","DOI":"10.1371\/journal.pone.0103345","article-title":"Hepatitis C virus infection epidemiology among people who inject drugs in Europe: a systematic review of data for scaling up treatment and prevention","volume":"9","author":"Wiessing","year":"2014","journal-title":"PLoS One"},{"issue":"9791","key":"10.1016\/j.cmi.2015.03.026_bib5","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0140-6736(11)61097-0","article-title":"Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews","volume":"378","author":"Nelson","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.cmi.2015.03.026_bib6","series-title":"European drug report 2014: trends and developments","year":"2014"},{"issue":"8","key":"10.1016\/j.cmi.2015.03.026_bib7","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1086\/605947","article-title":"Acute hepatitis C virus infection in young adult injection drug users: a prospective study of incident infection, resolution, and reinfection","volume":"200","author":"Page","year":"2009","journal-title":"J\u00a0Infect Dis"},{"issue":"10","key":"10.1016\/j.cmi.2015.03.026_bib8","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1093\/aje\/kwn237","article-title":"Meta-regression of hepatitis C virus infection in relation to time since onset of illicit drug injection: the influence of time and place","volume":"168","author":"Hagan","year":"2008","journal-title":"Am J Epidemiol"},{"issue":"Suppl.\u00a02","key":"10.1016\/j.cmi.2015.03.026_bib9","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1093\/cid\/cit300","article-title":"Injection drug use and hepatitis C virus infection in young adult injectors: using evidence to inform comprehensive prevention","volume":"57","author":"Page","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.cmi.2015.03.026_bib10","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1111\/j.1360-0443.2007.01912.x","article-title":"Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam Cohort Studies among drug users","volume":"102","author":"Van Den Berg","year":"2007","journal-title":"Addiction"},{"issue":"11","key":"10.1016\/j.cmi.2015.03.026_bib11","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1111\/j.1360-0443.2011.03515.x","article-title":"The impact of needle and syringe provision and opiate substitution therapy on the incidence of hepatitis C virus in injecting drug users: pooling of UK evidence","volume":"106","author":"Turner","year":"2011","journal-title":"Addiction"},{"issue":"5","key":"10.1016\/j.cmi.2015.03.026_bib12","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1093\/infdis\/jiq112","article-title":"Changes in blood-borne infection risk among injection drug users","volume":"203","author":"Mehta","year":"2011","journal-title":"J\u00a0Infect Dis"},{"issue":"no. RR-11","key":"10.1016\/j.cmi.2015.03.026_bib13","first-page":"1","article-title":"Updated Public Health Service guidelines for the management of health-care worker exposures to HIV and recommendations for postexposure prophylaxis","volume":"50","author":"Centers for Disease Control and Prevention","year":"2001","journal-title":"MMWR"},{"issue":"7","key":"10.1016\/j.cmi.2015.03.026_bib14","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1017\/S0950268807009417","article-title":"Epidemiological characteristics and medical follow-up of 61 patients with acute hepatitis C identified through the hepatitis C surveillance system in France","volume":"136","author":"Brouard","year":"2008","journal-title":"Epidemiol Infect"},{"issue":"11","key":"10.1016\/j.cmi.2015.03.026_bib15","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1136\/gut.2009.194266","article-title":"HCV iatrogenic and intrafamilial transmission in Greater Cairo, Egypt","volume":"59","author":"Paez Jimenez","year":"2010","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.cmi.2015.03.026_bib16","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/j.1365-2893.2012.01650.x","article-title":"Towards realistic estimates of HCV incidence in Egypt","volume":"20","author":"Breban","year":"2013","journal-title":"J\u00a0Viral Hepat"},{"issue":"3","key":"10.1016\/j.cmi.2015.03.026_bib17","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1002\/hep.26164","article-title":"Sexual transmission of hepatitis C virus among monogamous heterosexual couples: the HCV partners study","volume":"57","author":"Terrault","year":"2013","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.cmi.2015.03.026_bib18","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1097\/QAD.0000000000000126","article-title":"Trends in hepatitis C virus infections among MSM attending a sexually transmitted infection clinic; 1995\u20132010","volume":"28","author":"Urbanus","year":"2014","journal-title":"AIDS"},{"issue":"6","key":"10.1016\/j.cmi.2015.03.026_bib19","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1136\/sti.2006.021493","article-title":"Increase in hepatitis C virus incidence in HIV-1-infected patients followed up since primary infection","volume":"82","author":"Ghosn","year":"2006","journal-title":"Sex Transm Infect"},{"issue":"2","key":"10.1016\/j.cmi.2015.03.026_bib20","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1086\/518796","article-title":"Increase in HCV incidence among men who have sex with men in Amsterdam most likely caused by sexual transmission","volume":"196","author":"van de Laar","year":"2007","journal-title":"J\u00a0Infect Dis"},{"issue":"2","key":"10.1016\/j.cmi.2015.03.026_bib21","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1136\/sti.2007.027334","article-title":"Increase in diagnosed newly acquired hepatitis C in HIV-positive men who have sex with men across London and Brighton, 2002\u20132006: is this an outbreak?","volume":"84","author":"Giraudon","year":"2008","journal-title":"Sex Transm Infect"},{"issue":"10","key":"10.1016\/j.cmi.2015.03.026_bib22","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1093\/cid\/cis694","article-title":"Hepatitis C virus infections in the Swiss HIV Cohort Study: a rapidly evolving epidemic","volume":"55","author":"Wandeler","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.cmi.2015.03.026_bib23","doi-asserted-by":"crossref","first-page":"E111","DOI":"10.1097\/QAI.0000000000000208","article-title":"Stabilizing incidence of hepatitis C virus infection among men who have sex with men in Amsterdam","volume":"66","author":"Vanhommerig","year":"2014","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"issue":"1","key":"10.1016\/j.cmi.2015.03.026_bib24","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/cid\/cit197","article-title":"Incident hepatitis C virus infection in men who have sex with men: a prospective cohort analysis, 1984\u20132011","volume":"57","author":"Witt","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.cmi.2015.03.026_bib25","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/QAI.0000000000000044","article-title":"Incidence and risk factors for incident hepatitis C infection among men who have sex with men with HIV-1 infection in a large urban HIV clinic in Tokyo","volume":"65","author":"Nishijima","year":"2014","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"issue":"16","key":"10.1016\/j.cmi.2015.03.026_bib26","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1097\/QAD.0b013e32836381cc","article-title":"Hepatitis C virus reinfection incidence and treatment outcome among HIV-positive MSM","volume":"27","author":"Martin","year":"2013","journal-title":"AIDS"},{"issue":"17","key":"10.1016\/j.cmi.2015.03.026_bib27","doi-asserted-by":"crossref","first-page":"F21","DOI":"10.1097\/QAD.0b013e32834bac44","article-title":"Alarming incidence of hepatitis C virus re-infection after treatment of sexually acquired acute hepatitis C virus infection in HIV-infected MSM","volume":"25","author":"Lambers","year":"2011","journal-title":"AIDS"},{"issue":"5","key":"10.1016\/j.cmi.2015.03.026_bib28","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1053\/j.gastro.2009.02.006","article-title":"Evidence of a large, international network of HCV transmission in HIV-positive men who have sex with men","volume":"136","author":"van de Laar","year":"2009","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.cmi.2015.03.026_bib29","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1001\/jama.284.4.443","article-title":"The Internet as a newly emerging risk environment for sexually transmitted diseases","volume":"284","author":"McFarlane","year":"2000","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.cmi.2015.03.026_bib30","doi-asserted-by":"crossref","first-page":"e17781","DOI":"10.1371\/journal.pone.0017781","article-title":"Trouble with bleeding: risk factors for acute hepatitis C among HIV-positive gay men from Germany\u2014a case\u2013control study","volume":"6","author":"Schmidt","year":"2011","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.cmi.2015.03.026_bib31","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1097\/QAD.0b013e3281053a0c","article-title":"Recent epidemic of acute hepatitis C virus in HIV-positive men who have sex with men linked to high-risk sexual behaviours","volume":"21","author":"Danta","year":"2007","journal-title":"AIDS"},{"issue":"12","key":"10.1016\/j.cmi.2015.03.026_bib32","doi-asserted-by":"crossref","first-page":"F1","DOI":"10.1097\/QAD.0b013e32832e5631","article-title":"Hepatitis C virus infections among HIV-infected men who have sex with men: an expanding epidemic","volume":"23","author":"Urbanus","year":"2009","journal-title":"AIDS"},{"issue":"12","key":"10.1016\/j.cmi.2015.03.026_bib33","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1097\/QAD.0b013e32833c11a5","article-title":"Acute hepatitis C in HIV-infected men who have sex with men: an emerging sexually transmitted infection","volume":"24","author":"van de Laar","year":"2010","journal-title":"AIDS"},{"issue":"4","key":"10.1016\/j.cmi.2015.03.026_bib34","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1097\/MCG.0000000000000076","article-title":"Distinct features in natural history and outcomes of acute hepatitis C","volume":"49","author":"Bunchorntavakul","year":"2015","journal-title":"J Clin Gastroenterol"},{"issue":"6","key":"10.1016\/j.cmi.2015.03.026_bib35","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/j.jhep.2012.07.007","article-title":"Case definitions for acute hepatitis C virus infection: a systematic review","volume":"57","author":"Hajarizadeh","year":"2012","journal-title":"J\u00a0Hepatol"},{"issue":"2","key":"10.1016\/j.cmi.2015.03.026_bib36","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.jhep.2013.11.003","article-title":"EASL Clinical Practice Guidelines: management of hepatitis C virus infection","volume":"60","author":"European Association for Study of Liver","year":"2014","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1016\/j.cmi.2015.03.026_bib37","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/QAD.0b013e32831940a3","article-title":"Delayed anti-HCV antibody response in HIV-positive men acutely infected with HCV","volume":"23","author":"Thomson","year":"2009","journal-title":"AIDS"},{"issue":"12","key":"10.1016\/j.cmi.2015.03.026_bib38","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1093\/cid\/ciu695","article-title":"Hepatitis C virus (HCV) antibody dynamics following acute HCV infection and reinfection among HIV-infected men who have sex with men","volume":"59","author":"Vanhommerig","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.cmi.2015.03.026_bib39","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jcv.2013.01.002","article-title":"A\u00a0hepatitis C avidity test for determining recent and past infections in both plasma and dried blood spots","volume":"57","author":"Shepherd","year":"2013","journal-title":"J\u00a0Clin Virol"},{"issue":"2","key":"10.1016\/j.cmi.2015.03.026_bib40","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/cid\/ciu782","article-title":"Hepatitis C core antigen testing: a reliable, quick and potentially cost-effective alternative to hepatitis C polymerase chain reaction in diagnosing acute hepatitis C virus infection","volume":"60","author":"Cresswell","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.cmi.2015.03.026_bib41","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1136\/gut.2010.217166","article-title":"Predicting spontaneous clearance of acute hepatitis C virus in a large cohort of HIV-1-infected men","volume":"60","author":"Thomson","year":"2011","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.cmi.2015.03.026_bib42","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/hep.26639","article-title":"The effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C virus infection","volume":"59","author":"Grebely","year":"2014","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.cmi.2015.03.026_bib43","doi-asserted-by":"crossref","first-page":"4340","DOI":"10.1128\/JVI.79.7.4340-4346.2005","article-title":"Wide range of quasispecies diversity during primary hepatitis C virus infection","volume":"79","author":"Herring","year":"2005","journal-title":"J\u00a0Virol"},{"issue":"5386","key":"10.1016\/j.cmi.2015.03.026_bib44","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1126\/science.282.5386.103","article-title":"Hepatitis C viral dynamics in\u00a0vivo and the antiviral efficacy of interferon-alpha therapy","volume":"282","author":"Neumann","year":"1998","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.cmi.2015.03.026_bib45","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1001\/jama.284.4.450","article-title":"The natural history of hepatitis C virus infection: host, viral, and environmental factors","volume":"284","author":"Thomas","year":"2000","journal-title":"JAMA"},{"issue":"Suppl.\u00a03","key":"10.1016\/j.cmi.2015.03.026_bib46","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1093\/infdis\/jiu057","article-title":"Natural history and management of hepatitis C: does sex play a role?","volume":"209","author":"Baden","year":"2014","journal-title":"J\u00a0Infect Dis"},{"issue":"7265","key":"10.1016\/j.cmi.2015.03.026_bib47","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/nature08463","article-title":"Genetic variation in IL28B and spontaneous clearance of hepatitis C virus","volume":"461","author":"Thomas","year":"2009","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.cmi.2015.03.026_bib48","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1053\/j.gastro.2010.07.005","article-title":"A\u00a0polymorphism near IL28B is associated with spontaneous clearance of acute hepatitis C virus and jaundice","volume":"139","author":"Tillmann","year":"2010","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1016\/j.cmi.2015.03.026_bib49","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1086\/592171","article-title":"Spontaneous viral clearance, viral load, and genotype distribution of hepatitis C virus (HCV) in HIV-infected patients with anti-HCV antibodies in Europe","volume":"198","author":"Soriano","year":"2008","journal-title":"J\u00a0Infect Dis"},{"issue":"4","key":"10.1016\/j.cmi.2015.03.026_bib50","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.jhep.2014.06.014","article-title":"Occasional spontaneous clearance of chronic hepatitis C virus in HIV-infected individuals","volume":"61","author":"Stenkvist","year":"2014","journal-title":"J\u00a0Hepatol"},{"issue":"5","key":"10.1016\/j.cmi.2015.03.026_bib51","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.jhep.2013.06.028","article-title":"A\u00a0diagnostic score for the prediction of spontaneous resolution of acute hepatitis C virus infection","volume":"59","author":"Beinhardt","year":"2013","journal-title":"J\u00a0Hepatol"},{"issue":"2","key":"10.1016\/j.cmi.2015.03.026_bib52","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.jhep.2012.03.020","article-title":"Immediate vs. delayed treatment in patients with acute hepatitis C based on IL28B polymorphism: a model-based analysis","volume":"57","author":"Deuffic-Burban","year":"2012","journal-title":"J\u00a0Hepatol"},{"issue":"5","key":"10.1016\/j.cmi.2015.03.026_bib53","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1136\/gutjnl-2013-306287","article-title":"Additive effects of HLA alleles and innate immune genes determine viral outcome in HCV infection","volume":"64","author":"Fitzmaurice","year":"2015","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.cmi.2015.03.026_bib54","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jhep.2013.04.007","article-title":"Treatment optimization and prediction of HCV clearance in patients with acute HCV infection","volume":"59","author":"Mangia","year":"2013","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1016\/j.cmi.2015.03.026_bib55","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.cell.2009.06.036","article-title":"Redefining chronic viral infection","volume":"138","author":"Virgin","year":"2009","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.cmi.2015.03.026_bib56","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1084\/jem.194.10.1395","article-title":"Determinants of viral clearance and persistence during acute hepatitis C virus infection","volume":"194","author":"Thimme","year":"2001","journal-title":"J\u00a0Exp Med"},{"issue":"20","key":"10.1016\/j.cmi.2015.03.026_bib57","doi-asserted-by":"crossref","first-page":"12979","DOI":"10.1128\/JVI.79.20.12979-12988.2005","article-title":"Full-breadth analysis of CD8+ T-cell responses in acute hepatitis C virus infection and early therapy","volume":"79","author":"Lauer","year":"2005","journal-title":"J\u00a0Virol"},{"issue":"1","key":"10.1016\/j.cmi.2015.03.026_bib58","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1084\/jem.20100388","article-title":"Broadly directed virus-specific CD4+ T cell responses are primed during acute hepatitis C infection, but rapidly disappear from human blood with viral persistence","volume":"209","author":"Schulze Zur Wiesch","year":"2012","journal-title":"J\u00a0Exp Med"},{"issue":"12","key":"10.1016\/j.cmi.2015.03.026_bib59","doi-asserted-by":"crossref","first-page":"e492","DOI":"10.1371\/journal.pmed.0030492","article-title":"Impaired hepatitis C virus-specific T cell responses and recurrent hepatitis C virus in HIV coinfection","volume":"3","author":"Kim","year":"2006","journal-title":"PLoS Med"},{"issue":"1","key":"10.1016\/j.cmi.2015.03.026_bib60","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/hep.21242","article-title":"Outcome of acute hepatitis C is related to virus-specific CD4 function and maturation of antiviral memory CD8 responses","volume":"44","author":"Urbani","year":"2006","journal-title":"Hepatology"},{"issue":"30","key":"10.1016\/j.cmi.2015.03.026_bib61","doi-asserted-by":"crossref","first-page":"22741","DOI":"10.1074\/jbc.R109.099556","article-title":"Induction and evasion of innate antiviral responses by hepatitis C virus","volume":"285","author":"Lemon","year":"2010","journal-title":"J\u00a0Biol Chem"},{"issue":"7053","key":"10.1016\/j.cmi.2015.03.026_bib62","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/nature04078","article-title":"Evasion of intracellular host defence by hepatitis C virus","volume":"436","author":"Gale","year":"2005","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.cmi.2015.03.026_bib63","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1086\/427778","article-title":"CD8+ cell responses to hepatitis C virus (HCV) in the liver of persons with HCV\u2013HIV coinfection versus HCV monoinfection","volume":"191","author":"Alatrakchi","year":"2005","journal-title":"J\u00a0Infect Dis"},{"issue":"10","key":"10.1016\/j.cmi.2015.03.026_bib64","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1093\/infdis\/jis544","article-title":"Impaired hepatitis C virus (HCV)-specific interferon-gamma responses in individuals with HIV who acquire HCV infection: correlation with CD4(+) T-cell counts","volume":"206","author":"Flynn","year":"2012","journal-title":"J\u00a0Infect Dis"},{"issue":"6","key":"10.1016\/j.cmi.2015.03.026_bib65","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1365-2893.2007.00963.x","article-title":"HCV-specific T-cell responses in injecting drug users: evidence for previous exposure to HCV and a role for CD4+ T cells focussing on nonstructural proteins in viral clearance","volume":"15","author":"Ruys","year":"2008","journal-title":"J\u00a0Viral Hepat"},{"key":"10.1016\/j.cmi.2015.03.026_bib66","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.antiviral.2014.02.013","article-title":"The past, present and future of neutralizing antibodies for hepatitis C virus","volume":"105","author":"Ball","year":"2014","journal-title":"Antiviral Res"},{"issue":"1","key":"10.1016\/j.cmi.2015.03.026_bib67","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1128\/JVI.01592-10","article-title":"Neutralizing antibody-resistant hepatitis C virus cell-to-cell transmission","volume":"85","author":"Brimacombe","year":"2011","journal-title":"J\u00a0Virol"},{"issue":"10","key":"10.1016\/j.cmi.2015.03.026_bib68","doi-asserted-by":"crossref","first-page":"810","DOI":"10.7326\/0003-4819-128-10-199805150-00003","article-title":"Incidence of hepatitis C in patients receiving different preparations of hepatitis B immunoglobulins after liver transplantation","volume":"128","author":"Feray","year":"1998","journal-title":"Ann Intern Med"},{"issue":"14","key":"10.1016\/j.cmi.2015.03.026_bib69","doi-asserted-by":"crossref","first-page":"6025","DOI":"10.1073\/pnas.0607026104","article-title":"Rapid induction of virus-neutralizing antibodies and viral clearance in a single-source outbreak of hepatitis C.","volume":"104","author":"Pestka","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"issue":"41","key":"10.1016\/j.cmi.2015.03.026_bib70","doi-asserted-by":"crossref","first-page":"16269","DOI":"10.1073\/pnas.0705522104","article-title":"Human combinatorial libraries yield rare antibodies that broadly neutralize hepatitis C virus","volume":"104","author":"Johansson","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"issue":"17","key":"10.1016\/j.cmi.2015.03.026_bib71","doi-asserted-by":"crossref","first-page":"11095","DOI":"10.1128\/JVI.79.17.11095-11104.2005","article-title":"Monoclonal antibody AP33 defines a broadly neutralizing epitope on the hepatitis C virus E2 envelope glycoprotein","volume":"79","author":"Owsianka","year":"2005","journal-title":"J\u00a0Virol"},{"issue":"3","key":"10.1016\/j.cmi.2015.03.026_bib72","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1002\/hep.21088","article-title":"Characterization of the hepatitis C virus E2 epitope defined by the broadly neutralizing monoclonal antibody AP33","volume":"43","author":"Tarr","year":"2006","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.cmi.2015.03.026_bib73","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1038\/nm.3183","article-title":"Current progress in development of hepatitis C virus vaccines","volume":"19","author":"Liang","year":"2013","journal-title":"Nat Med"},{"issue":"4","key":"10.1016\/j.cmi.2015.03.026_bib74","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1586\/erv.13.15","article-title":"Development of chimpanzee adenoviruses as vaccine vectors: Challenges and successes emerging from clinical trials","volume":"12","author":"Capone","year":"2013","journal-title":"Expert Rev Vaccines"},{"issue":"8","key":"10.1016\/j.cmi.2015.03.026_bib75","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1517\/14712598.2013.791277","article-title":"Ever closer to a prophylactic vaccine for HCV","volume":"13","author":"Swadling","year":"2013","journal-title":"Expert Opin Biol Ther"},{"issue":"10","key":"10.1016\/j.cmi.2015.03.026_bib76","doi-asserted-by":"crossref","first-page":"5502","DOI":"10.1128\/JVI.03574-13","article-title":"Combined adenovirus vector and hepatitis C virus envelope protein prime-boost regimen elicits T cell and neutralizing antibody immune responses","volume":"88","author":"Chmielewska","year":"2014","journal-title":"J\u00a0Virol"},{"issue":"115","key":"10.1016\/j.cmi.2015.03.026_bib77","doi-asserted-by":"crossref","first-page":"115ra1","DOI":"10.1126\/scitranslmed.3003155","article-title":"Novel adenovirus-based vaccines induce broad and sustained T cell responses to HCV in man","volume":"4","author":"Barnes","year":"2012","journal-title":"Sci Transl Med"},{"issue":"6","key":"10.1016\/j.cmi.2015.03.026_bib78","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1002\/hep.26991","article-title":"Acute hepatitis C: a 24-week course of pegylated interferon alpha-2b versus a 12-week course of pegylated interferon alpha-2b alone or with ribavirin","volume":"59","author":"Santantonio","year":"2014","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.cmi.2015.03.026_bib79","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S1473-3099(13)70059-8","article-title":"Delayed versus immediate treatment for patients with acute hepatitis C: a randomised controlled non-inferiority trial","volume":"13","author":"Deterding","year":"2013","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"10.1016\/j.cmi.2015.03.026_bib80","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/hep.21043","article-title":"Early monotherapy with pegylated interferon alpha-2b for acute hepatitis C infection: the HEP-NET acute-HCV-II study","volume":"43","author":"Wiegand","year":"2006","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.cmi.2015.03.026_bib81","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jhep.2004.11.021","article-title":"Efficacy of a 24-week course of PEG-interferon alpha-2b monotherapy in patients with acute hepatitis C after failure of spontaneous clearance","volume":"42","author":"Santantonio","year":"2005","journal-title":"J\u00a0Hepatol"},{"issue":"4","key":"10.1016\/j.cmi.2015.03.026_bib82","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/QAD.0b013e328343443b","article-title":"recommendations from the European AIDS Treatment Network (NEAT) consensus conference","volume":"25","author":"Acute hepatitis C in HIV-infected individuals","year":"2011","journal-title":"AIDS"},{"issue":"11","key":"10.1016\/j.cmi.2015.03.026_bib83","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1111\/jvh.12272","article-title":"Peginterferon-alfa mono-therapy in the treatment of acute hepatitis C in HIV-infection","volume":"21","author":"Boesecke","year":"2014","journal-title":"J\u00a0Viral Hepat"},{"issue":"2","key":"10.1016\/j.cmi.2015.03.026_bib84","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1093\/jac\/dki458","article-title":"Dose-dependent and genotype-independent sustained virological response of a 12 week pegylated interferon alpha-2b treatment for acute hepatitis C","volume":"57","author":"De Rosa","year":"2006","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"2","key":"10.1016\/j.cmi.2015.03.026_bib85","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/j.1365-2893.2006.00802.x","article-title":"A\u00a0short course of pegylated interferon-alpha in acute HCV hepatitis","volume":"14","author":"Calleri","year":"2007","journal-title":"J\u00a0Viral Hepat"},{"issue":"1","key":"10.1016\/j.cmi.2015.03.026_bib86","first-page":"43","article-title":"Treatment of acute hepatitis C virus infection in HIV+ patients: Dutch recommendations for management","volume":"69","author":"Arends","year":"2011","journal-title":"Neth J Med"},{"issue":"6","key":"10.1016\/j.cmi.2015.03.026_bib87","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1093\/cid\/cit799","article-title":"Telaprevir in the treatment of acute hepatitis C virus infection in HIV-infected men","volume":"58","author":"Fierer","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.cmi.2015.03.026_bib88","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/jvh.12348","article-title":"How will we manage acute HCV in men having sex with men in the era of all oral therapy?","volume":"22","author":"Boesecke","year":"2015","journal-title":"J\u00a0Viral Hepat"},{"issue":"1","key":"10.1016\/j.cmi.2015.03.026_bib89","doi-asserted-by":"crossref","first-page":"e1002876","DOI":"10.1371\/journal.pcbi.1002876","article-title":"Integrating phylodynamics and epidemiology to estimate transmission diversity in viral epidemics","volume":"9","author":"Magiorkinis","year":"2013","journal-title":"PLoS Comput Biol"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X15004061?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X15004061?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,5]],"date-time":"2022-05-05T05:20:51Z","timestamp":1651728051000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X15004061"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":89,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S1198743X15004061"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2015.03.026","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]}}}